Halozyme Enters Into Global Collaboration and Licensing Agreement With AbbVie
Go back to Halozyme Enters Into Global Collaboration and Licensing Agreement With AbbVie| AbbVie (NYSE: ABBV) | Delayed: 264.96 +3.13 (1.20%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $261.83 | 52 Week High | $68.12 | |||
| Open | $260.70 | 52 Week Low | $50.71 | |||
| Day High | $266.84 | P/E | 57.48 | |||
| Day Low | $260.10 | EPS | $4.61 | |||
| Volume | 5,157,114 | |||||
| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 108.17 +2.05 (1.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $106.12 | 52 Week High | $18.39 | |||
| Open | $106.20 | 52 Week Low | $6.96 | |||
| Day High | $108.49 | P/E | N/A | |||
| Day Low | $105.91 | EPS | $-0.58 | |||
| Volume | 1,173,974 | |||||
